Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
0.5985
-0.0370 (-5.82%)
May 7, 2025, 4:00 PM EDT - Market closed

Alzamend Neuro Ratios and Metrics

Millions USD. Fiscal year is May - Apr.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2016 - 2019
Period Ending
May '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 2016 - 2019
Market Capitalization
455395--
Upgrade
Market Cap Growth
8.59%-90.80%-44.08%---
Upgrade
Enterprise Value
154683--
Upgrade
Last Close Price
0.607.1182.09153.00--
Upgrade
PB Ratio
1.00-1.8817.427.11--
Upgrade
P/TBV Ratio
1.14-17.427.11--
Upgrade
Debt / Equity Ratio
--0.12--0.170.08
Upgrade
Quick Ratio
4.630.121.7912.072.160.19
Upgrade
Current Ratio
5.440.142.0312.373.241.83
Upgrade
Return on Equity (ROE)
--4408.31%-181.47%-160.92%-356.06%-774.66%
Upgrade
Return on Assets (ROA)
-106.08%-189.73%-90.97%-88.35%-130.96%-166.83%
Upgrade
Return on Capital (ROIC)
--1651.80%-113.36%-98.09%-191.48%-431.84%
Upgrade
Earnings Yield
-107.50%-203.75%-28.04%-13.03%--
Upgrade
FCF Yield
-188.10%-172.40%-16.82%-7.08%--
Upgrade
Buyback Yield / Dilution
-294.83%-4.07%-9.46%-22.64%-1.96%-21.09%
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q